Comparison between Chavda Infra IPO and Saroja Pharma IPO.
Chavda Infra IPO is a SME Fixed Price IPO proposed to list at NSE SME while Saroja Pharma IPO is a SME Fixed Price proposed to list at NSE SME.
| Chavda Infra IPO | Saroja Pharma IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Swastika Investmart Ltd. |
| Registrar | Kfin Technologies Ltd. | Kfin Technologies Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Swastika Investmart Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Chavda Infra IPO is up to ₹41.08 Cr whereas the issue size of the Saroja Pharma IPO is up to ₹8.66 Cr. The final issue price of Chavda Infra IPO is ₹65.00 per share and of Saroja Pharma IPO is ₹84.00 per share.
| Chavda Infra IPO | Saroja Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹60.00 per share | |
| Issue Price (Upper) | ₹65.00 per share | |
| Issue Price (Final) | ₹65.00 per share | ₹84.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 63,20,000 shares | 10,30,400 shares |
| Fresh Issue Size (Amount) | up to ₹41.08 Cr | up to ₹8.66 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 63,20,000 shares | 10,30,400 shares |
| Issue Size Total (Amount) | up to ₹41.08 Cr | up to ₹8.66 Cr |
Chavda Infra IPO opens on Sep 12, 2023, while Saroja Pharma IPO opens on Aug 31, 2023. The closing date of Chavda Infra IPO and Saroja Pharma IPO is Sep 14, 2023, and Sep 05, 2023, respectively.
| Chavda Infra IPO | Saroja Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Sep 11, 2023 | |
| Issue Open | Sep 12, 2023 | Aug 31, 2023 |
| Issue Close | Sep 14, 2023 | Sep 05, 2023 |
| Basis Of Allotment (Tentative) | Sep 20, 2023 | Sep 08, 2023 |
| Initiation of Refunds (Tentative) | Sep 21, 2023 | Sep 11, 2023 |
| Credit of Share (Tentative) | Sep 22, 2023 | Sep 12, 2023 |
| Listing date (Tentative) | Sep 25, 2023 | Sep 13, 2023 |
| Anchor Lockin End date 1 | Oct 20, 2023 | |
| Anchor Lockin End date 2 | Dec 19, 2023 |
Chavda Infra IPO P/E ratio is 9.72, as compared to Saroja Pharma IPO P/E ratio of 23.25.
| Chavda Infra IPO | Saroja Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73 | 73.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.72 | 23.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹160.26 Cr. | ₹33.77 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 49.41% | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 43.62% | 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.75 | 2.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.69 | ₹3.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 39.62% | 20.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Chavda Infra IPO Retail Individual Investors (RII) are offered 22,12,000 shares while in Saroja Pharma IPO retail investors are offered 22,12,000 shares. Qualified Institutional Buyers (QIB) are offered 12,64,000 shares in Chavda Infra IPO and in Saroja Pharma IPO.
| Chavda Infra IPO | Saroja Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 18,96,000 shares | |
| Market Maker Reservation | 3,36,000 shares | 54,400 shares |
| QIB | 12,64,000 shares | |
| NII | 9,48,000 shares | 5,15,200 shares |
| RII | 22,12,000 shares | 5,15,200 shares |
| Employee | ||
| Others | ||
| Total | 63,20,000 shares | 10,30,400 shares |
Chavda Infra IPO subscribed 180.06x in total, whereas Saroja Pharma IPO subscribed 8.88x.
| Chavda Infra IPO | Saroja Pharma IPO | |
|---|---|---|
| QIB (times) | 95.10x | |
| NII (times) | 241.96x | 2.90x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 202.07x | 14.83x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 180.06x | 8.88x |
